Literature DB >> 20503279

Ventilatory parameters and maximal respiratory pressure changes with age in Duchenne muscular dystrophy patients.

Jerome Gayraud1, Michele Ramonatxo, François Rivier, Véronique Humberclaude, Basil Petrof, Stefan Matecki.   

Abstract

The aim of this longitudinal study was to precise, in children with Duchenne muscular dystrophy, the respective functional interest of ventilatory parameters (Vital capacity, total lung capacity and forced expiratory volume in one second [FEV(1)]) in comparison to maximal inspiratory pressure (Pimax) during growth. In ten boys the mean age of 9.1 +/- 1 years) to mean age of 16 +/- 1.4 years followed over a period of 7 years, we found that: (1) ventilatory parameters expressed in percentage of predicted value, after a normal ascending phase, start to decrease between 11 and 12 years, (2) Pimax presented only a decreasing phase since the beginning of the study and thus was already at 67% of predicted value at 12 years while ventilatory parameters was still normal, (3) after 12 years the mean slopes of decrease per year of vital capacity and FEV1 were higher (10.7 and 10.4%) than that of Pimax (6.9%), (4) at 15 years mean values of vital capacity and FEV1 (53.3 and 49.5% of predicted values) was simlar to that of Pimax (48.3%). In conclusion, if at early stages of the disease, Pimax is a more reliable index of respiratory impaiment than ventilatory parameters, the follow-up of ventilatory parameters, when they start to decrease, is a better indicator of disease progression and, at advanced stages they provided same information about the functional impact of disease.

Entities:  

Mesh:

Year:  2010        PMID: 20503279     DOI: 10.1002/ppul.21204

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  18 in total

Review 1.  Sleep Disordered Breathing in Duchenne Muscular Dystrophy.

Authors:  Antonella LoMauro; Maria Grazia D'Angelo; Andrea Aliverti
Journal:  Curr Neurol Neurosci Rep       Date:  2017-05       Impact factor: 5.081

2.  Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.

Authors:  Christine Péladeau; Aatika Ahmed; Adel Amirouche; Tara E Crawford Parks; Lucas M Bronicki; Vladimir Ljubicic; Jean-Marc Renaud; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2015-10-22       Impact factor: 6.150

3.  Effects of home-based respiratory muscle training in children and adolescents with chronic lung disease.

Authors:  Iván Rodríguez Núñez; Daniel Zenteno Araos; Carlos Manterola Delgado
Journal:  J Bras Pneumol       Date:  2014 Nov-Dec       Impact factor: 2.624

4.  Effect of Yoga and Physiotherapy on Pulmonary Functions in Children with Duchenne Muscular Dystrophy - A Comparative Study.

Authors:  Pradnya Dhargave; Atchayaram Nalini; Raghuram Nagarathna; Raghupathy Sendhilkumar; Tittu Thomas James; Trichur R Raju; Talakad N Sathyaprabha
Journal:  Int J Yoga       Date:  2021-05-10

5.  Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy.

Authors:  Darlene L Machado; Elaine C Silva; Maria B D Resende; Celso R F Carvalho; Edmar Zanoteli; Umbertina C Reed
Journal:  BMC Res Notes       Date:  2012-08-13

Review 6.  Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options.

Authors:  Antonella LoMauro; Maria Grazia D'Angelo; Andrea Aliverti
Journal:  Ther Clin Risk Manag       Date:  2015-09-28       Impact factor: 2.423

7.  Unidirectional Expiratory Valve Method to Assess Maximal Inspiratory Pressure in Individuals without Artificial Airway.

Authors:  Samantha Torres Grams; Karen Yumi Mota Kimoto; Elen Moda de Oliveira Azevedo; Marina Lança; André Luis Pereira de Albuquerque; Christina May Moran de Brito; Wellington Pereira Yamaguti
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

8.  Improving clinical trial design for Duchenne muscular dystrophy.

Authors:  Luciano Merlini; Patrizia Sabatelli
Journal:  BMC Neurol       Date:  2015-08-26       Impact factor: 2.474

9.  Ventilatory chemosensory drive is blunted in the mdx mouse model of Duchenne Muscular Dystrophy (DMD).

Authors:  Matias Mosqueira; Santhosh M Baby; Sukhamay Lahiri; Tejvir S Khurana
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

Review 10.  Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.

Authors:  Ashling Holland; Kay Ohlendieck
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.